DarioHealth Corp. Increase (Decrease) in Accounts Receivable
DarioHealth Corp. (DRIO) reported Increase (Decrease) in Accounts Receivable of $257.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2016-11-10
- 2016-09-30: Increase (Decrease) in Accounts Receivable 9 month $257.00K.
- 2015-09-30: Increase (Decrease) in Accounts Receivable 9 month $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 9 month |
|---|---|
| 2016-09-30 | $257.00K 10-Q · filed 2016-11-10 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |